<DOC>
	<DOCNO>NCT02906488</DOCNO>
	<brief_summary>The purpose study assess safety efficacy long-term use Duodopa patient Parkinson 's disease actual usage</brief_summary>
	<brief_title>Special Drug Use-results Survey Duodopa Enteral Solution Patients With Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Carbidopa , levodopa drug combination</mesh_term>
	<criteria>1 . Patients Parkinson 's disease use Duodopa purpose improve circadian change ( wearingoff phenomenon ) symptoms Parkinson 's disease sufficient effect obtain exist drug therapy include levodopacontaining drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Quality life</keyword>
</DOC>